Neutral endopeptidase inhibits neuropeptide-mediated transactivation of the insulin-like growth factor receptor-Akt cell survival pathway

Cancer Research

Volumn 61, Issue 8, 2001, Pages 3294-3298

  Sumitomo, Makoto ^a,b   Milowsky, Matthew I ^a   Shen, Ruoqian ^a   Navarro, Daniel ^a   Dai, Jie ^a   Asano, Tomohiko ^b   Hayakawa, Masamichi ^b   Nanus, David M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; BOMBESIN; CGS 24592; ENDOTHELIN 1; ENKEPHALINASE INHIBITOR; G PROTEIN COUPLED RECEPTOR; MEMBRANE METALLOENDOPEPTIDASE; MITOGEN ACTIVATED PROTEIN KINASE; NEUROPEPTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; PROTEIN KINASE P60; PROTEIN SERINE THREONINE KINASE; PROTEIN SERINE THREONINE KINASE AKT; RECEPTOR SUBUNIT; RECOMBINANT ENZYME; RECOMBINANT NEUTRAL ENDOPEPTIDASE; SOMATOMEDIN C RECEPTOR; SOMATOMEDIN RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CELL COMMUNICATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSACTIVATION;

BOMBESIN; CELL SURVIVAL; ENDOTHELIN-1; ENZYME ACTIVATION; HUMANS; MALE; NEPRILYSIN; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED;

EID: 0035870258     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Neurotensin is an autocrine trophic factor stimulated by androgen withdrawal in human prostate cancer
2. Endothelin-1 production and decreased endotbelin B receptor expression in advanced prostate cancer
3. Gastrin-releasing peptide receptors in the human prostate: Relation to neoplastic transformation
4. Signal transduction pathways in the mitogenic response to G protein-coupled neuropeptide receptor agonists
5. Inhibition of neuropeptide-stimulated tyrosine phosphorylation and tyrosine kinase activity stimulates apoptosis in small cell lung cancer cells
6. Endothelin receptor blockade potentiates FasL-induced apoptosis in rat colon carcinoma cells
7. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
8. Antiapoptotic signaling in LNCaP prostate cancer cells: A survival signaling pathway independent of phosphatidylinositol 3′-kinase and Akt/protein kinase B
9. Akt phosphorylation of BAD couples survival signals to the cell- intrinsic death machinery
10. Regulation of cell death protease caspase-9 by phosphorylation
11. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3′-kinase pathway
12. Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression
13. Thrombin stimulates phosphorylation of insulin-like growth factor-1 receptor, insulin receptor substrate-1, and phospholipase C-γ 1 in rat aortic smooth muscle cells
14. G-protein and tyrosine kinase receptor cross-talk in rat aortic smooth muscle cells: Thrombin- and angiotensin II-induced tyrosine phosphorylation of insulin receptor substrate-1 and insulin-like growth factor 1 receptor
15. Biphasic activation of p21ras by endothelin-1 sequentially activates the ERK cascade and phosphatidylinositol 3-kinase
16. Function of PI3Kγ in thymocyte development, T cell activation, and neutrophil migration
17. CD10/neutral endopeptidase 24.11 hydrolyzes bombesin-like peptides and regulates the growth of small cell carcinomas of the lung
18. Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression
19. Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling
20. Neutral endopeptidase promotes phorbol ester-induced apoptosis in prostate cancer cells by inhibiting neuropeptide-induced protein kinase C δ degradation
21. Src phosphorylates the insulin-like growth factor type 1 receptor on the autophosphorylation sites. Requirement for transformation by src
22. Activation of protein kinase cascades in the heart by hypertrophic G protein-coupled receptor agonists
23. Stimulation of protein kinase C modulates insulin-like growth factor-1- induced akt activation in PC12 cells
24. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors
25. Convergence of angiotensin II and platelet-derived growth factor receptor signaling cascades in vascular smooth muscle cells
26. The protein kinase encoded by the Akt protooncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase
27. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction
28. The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development
29. Plasma insulin-like growth factor-1 and prostate cancer risk: A prospective study
30. Deregulated expression of insulin-like growth factor I in prostate epithelium leads to neoplasia in transgenic mice
31. Hormonal predictors of prostate cancer: A meta-analysis
32. Insulin-like growth factors and prostate cancer
33. Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways
34. c phosphorylation and activation of the IGF-I receptor in src-transformed cells
35. HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway
36. Tumor suppressive effects of neutral endopeptidase in androgen-independent prostate cancer cells
37. Characterization of two androgen-responsive regions in the human neutral endopeptidase gene
38. Methylation of the neutral endopeptidase gene promoter in human prostate cancers